The bidirectional influence between type 2 diabetes mellitus and the state of depression and anxiety
- PMID: 40419162
- DOI: 10.1016/j.jad.2025.119467
The bidirectional influence between type 2 diabetes mellitus and the state of depression and anxiety
Abstract
Type 2 diabetes mellitus (T2DM) is a prevalent chronic disease with several complications that has a negative impact on patients' physical and mental health. People's life pressures are increasing as society develop, resulting in a series of adverse emotions. If it is not paid attention to for a long time, it will lead to depression, anxiety, and other mental disorders. Depression and anxiety can occur separately or simultaneously, both of which are highly correlated. In recent years, the incidence of T2DM with the state of depression and anxiety has increased significantly. According to recent research, the state of depression and anxiety might increase the prevalence of T2DM and accelerate its progression by influencing patient's behavioral style and biological mechanisms. T2DM can also aggravate patients' state of depression and anxiety, worsening their life quality. However, few reviews have discussed the association between T2DM and the state of depression and anxiety. In order to reduce the prevalence of the two diseases, we ought to investigate them more thoroughly so that readers can recognize the close connection between the two and take appropriate interventions. Therefore, this article mainly discusses the interaction between T2DM and the state of depression and anxiety from behavioral and biological mechanisms, the effects of common hypoglycemic drugs on the state of depression and anxiety, and the effects of antidepressant anxiety treatments on T2DM. These three aspects are intended to shed light on the interaction between the two so as to find the appropriate interventions to reduce morbidity.
Keywords: Antidepressant anxiety; Hypoglycemic drug; Hypothalamus-pituitary-adrenal axis; The state of depression and anxiety; Type 2 diabetes mellitus.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Depression in type 2 diabetes mellitus: prevalence, impact, and treatment.Drugs. 2015 Apr;75(6):577-87. doi: 10.1007/s40265-015-0347-4. Drugs. 2015. PMID: 25851098 Review.
-
Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes.J Endocrinol Invest. 2008 Nov;31(11):1020-4. doi: 10.1007/BF03345642. J Endocrinol Invest. 2008. PMID: 19169060
-
Epidemiology of antidepressant medication use in the Canadian diabetes population.Soc Psychiatry Psychiatr Epidemiol. 2010 Sep;45(9):911-9. doi: 10.1007/s00127-009-0129-y. Soc Psychiatry Psychiatr Epidemiol. 2010. PMID: 19730761
-
How an age of anxiety became an age of depression.Milbank Q. 2010 Mar;88(1):112-38. doi: 10.1111/j.1468-0009.2010.00591.x. Milbank Q. 2010. PMID: 20377760 Free PMC article. Review.
-
Association between depression and persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients in Germany.Psychiatry Res. 2018 Mar;261:90-93. doi: 10.1016/j.psychres.2017.12.058. Epub 2017 Dec 21. Psychiatry Res. 2018. PMID: 29291478
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical